Status:
COMPLETED
Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males
Lead Sponsor:
Acrux DDS Pty Ltd
Conditions:
Hypogonadism
Eligibility:
MALE
18-70 years
Phase:
PHASE2
Brief Summary
Testosterone replacement treatment is the most effective way of treating hypogonadism in men. Acrux has a proprietry testosterone replacement product - Testosterone-MD Lotion, and this study will eval...
Eligibility Criteria
Inclusion
- Hypogonadal males between 18-70 years old with qualifying general medical health
Exclusion
- Disqualifying concurrent conditions or allergy/sensitivity to testosterone replacement therapy
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00372008
Start Date
October 1 2006
End Date
April 1 2007
Last Update
June 20 2008
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham
Birmingham, Alabama, United States
2
La Mesa, California, United States
3
Torrance, California, United States
4
New Britain, Connecticut, United States